Biotechnology News

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing...

RESEARCH TRIANGLE PARK, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- Merakris Therapeutics, Inc., a clinical-stage biotechnology company developing regenerative biologic medicines for chronic wounds,...

PLYMOUTH MEETING, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2026 financial results on Tuesday,...

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of VYNE’s...

GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people...

Lonza grants Engitix target-specific license for GlycoConnect®, HydraSpace® and SYNtecan E™ linker-payload technologies for ADC developmentCollaboration enables innovative treatments by combining...

Company receives positive pre-IND feedback from US FDA for CLD-401, indicating agreement on its current development strategy as it advances towards a first-in-human study; targeting dosing first...

European Patent Office confirms patent protection for SOT201, next-gen PD-1-targeting immunocytokine currently being evaluated in a Phase 1 clinical trial

Global Expansion Complete as Germany Joins Ongoing Study of Inhaled LTI-03 in Idiopathic Pulmonary FibrosisCompany on track to report initial topline data in 2H 2026 AUSTIN, Texas, July 21, 2026 ...

PatientsLikeMe and Science 37 partner to help pharmaceutical and biotechnology sponsors accelerate clinical development.